Seungman Park
Papers
1
Total Citations
2
H-Index
1
About
Dr. Seungman Park is a leading figure in clinical mass spectrometry and laboratory automation, with a focus on advancing therapeutic drug monitoring and diagnostic accuracy. His most cited work, a 2023 study evaluating the Andrew+ robotic liquid handler for LC-MS/MS-based quantitation of immunosuppressants in whole blood, demonstrates his commitment to integrating robotics into clinical workflows. This research, which has garnered early citations, showcases how automated sample preparation can enhance reproducibility, reduce human error, and improve throughput in high-stakes pharmacometric testing. Dr. Park’s contributions lie at the intersection of analytical chemistry and clinical medicine, particularly in optimizing pre-analytical processes for complex matrices. By validating robotic systems for immunosuppressant monitoring—critical for transplant patients—he addresses a pressing need for standardization in clinical mass spectrometry. His work not only streamlines laboratory operations but also sets a benchmark for future automation in diagnostic toxicology. Through collaborative studies with multidisciplinary teams, Dr. Park continues to shape the evolution of precision medicine, ensuring that technological innovations translate into tangible improvements in patient care and laboratory efficiency.
Research Focus
Key Achievements
Top Papers
- 1